Skip to main content

BRIEF-Cytokinetics and Royalty Pharma announce $100 million transaction for Omecamtiv Mecarbil

* Cytokinetics and Royalty Pharma announce $100 million transaction for Omecamtiv Mecarbil
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.